BEIGENE, LTD.
NASDAQ: ONC (BeOne Medicines Ltd.)
Kemas kini terakhir: 16 jam lalu331.40
-6.46 (-1.91%)
| Penutupan Terdahulu | 337.86 |
| Buka | 334.95 |
| Jumlah Dagangan | 237,192 |
| Purata Dagangan (3B) | 275,065 |
| Modal Pasaran | 36,672,040,960 |
| Harga / Pendapatan (P/E TTM) | 649.80 |
| Harga / Pendapatan (P/E Ke hadapan) | 40.98 |
| Harga / Jualan (P/S) | 7.39 |
| Harga / Buku (P/B) | 8.85 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -9.40% |
| Margin Operasi (TTM) | 0.99% |
| EPS Cair (TTM) | -3.69 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 48.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 28.49% |
| Nisbah Semasa (MRQ) | 1.96 |
| Aliran Tunai Operasi (OCF TTM) | 212.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -120.68 M |
| Pulangan Atas Aset (ROA TTM) | -3.22% |
| Pulangan Atas Ekuiti (ROE TTM) | -11.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | BeOne Medicines Ltd. | Menaik | - |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | 1.00 |
|
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne’s revenue. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 17.31% |
| % Dimiliki oleh Institusi | 43.94% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Baird Financial Group, Inc. | 30 Sep 2025 | 342,922 |
| Capital International, Inc./Ca/ | 30 Sep 2025 | 325,844 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 408.00 (RBC Capital, 23.11%) | Beli |
| Median | 396.00 (19.49%) | |
| Rendah | 383.00 (Morgan Stanley, 15.57%) | Beli |
| Purata | 394.57 (19.06%) | |
| Jumlah | 7 Beli | |
| Harga Purata @ Panggilan | 336.91 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Truist Securities | 24 Nov 2025 | 400.00 (20.70%) | Beli | 332.71 |
| RBC Capital | 18 Nov 2025 | 408.00 (23.11%) | Beli | 363.92 |
| 07 Nov 2025 | 395.00 (19.19%) | Beli | 319.97 | |
| Citigroup | 10 Nov 2025 | 405.00 (22.21%) | Beli | 329.20 |
| Citizens | 07 Nov 2025 | 396.00 (19.49%) | Beli | 319.97 |
| Morgan Stanley | 20 Oct 2025 | 383.00 (15.57%) | Beli | 318.59 |
| JP Morgan | 08 Oct 2025 | 385.00 (16.17%) | Beli | 351.09 |
| Barclays | 18 Sep 2025 | 385.00 (16.17%) | Beli | 342.89 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| SANDERS CORAZON (CORSEE) D. | - | 340.64 | -2,627 | -894,861 |
| Jumlah Keseluruhan Kuantiti Bersih | -2,627 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -894,861 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 340.64 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| SANDERS CORAZON (CORSEE) D. | Pengarah | 26 Nov 2025 | Jual (-) | 2,627 | 340.64 | 894,861 |
| SANDERS CORAZON (CORSEE) D. | Pengarah | 26 Nov 2025 | Pelaksanaan pilihan | 2,627 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |